Trinity Biotech | TRIB - Current Liabilities


Trinity Biotech reported $34.49M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Bayer EUR 28.96B 825M Sep/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
EDAP TMS EUR 34.12M 562K Jun/2025
J&J USD 54.13B 3.26B Dec/2025
Mesa Laboratories USD 54.4M 6.1M Dec/2025
OraSure Technologies USD 40.25M 2.1M Sep/2025
Plus Therapeutics USD 10.73M 189K Dec/2023
Roche Holding CHF 28B 421M Dec/2025
Siemens EUR 49.35B 2.09B Dec/2025
Surmodics USD 20.54M 347K Sep/2024
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Tosoh JPY 340.28B 25.85B Dec/2025
Trinity Biotech USD 34.49M 2.97M Sep/2025
Veracyte USD 72.15M 4.28M Sep/2025